Athira Pharma, Inc. ATHA
Set alert
6.75 USD 0.00 0.00%
At close · Jan 9
6.95 +0.20 +2.96%
After hours · Jan 9, 4:00 PM ET
6.61 Day range 7.35
52-week range unavailable
- YTD
- -10.83%
- 1 year
- +112.26%
- Open
- 7.30
- Prev close
- 6.75
- Mkt cap
- 20.96M
- Vol
- 70.31K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.61
- High
- 7.35
- Forward P/E
- -0.33
- Beta
- 2.83
- Short ratio
- 2.74
- Inst. own
- 62.14%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 1, 2024
- 50-d avg
- 0.58974
- 200-d avg
- 1.84
- 1y target
- 0.55
Financial health
Altman Z-Score
-12.39 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.3×
FY 2018 5y median -0.8× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.2×
FY 2018 5y median 0.7× FY 2025
P/FCF -0.7×
FY 2018 5y median -0.9× FY 2025
EV/EBITDA -56.2×
FY 2018 5y median -0.3× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -141.3%
FY 2018 5y median -109.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -380.0%
FY 2018 5y median -90.4% FY 2025
ROIC -226.7%
FY 2018 5y median -95.2% FY 2025
ROA -114.6%
FY 2018 5y median -73.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -1.4%
FY 2018 FY 2025
EPS (diluted) 2.0%
FY 2018 FY 2025
Free Cash Flow 53.0%
FY 2018 FY 2025
Financial Health
Current Ratio 1.9×
FY 2018 5y median 5.4× FY 2025
Quick Ratio 1.9×
FY 2018 5y median 5.4× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -106×
FY 2018 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
